Medifast Inc

MED

$65.90

-40.7% last 12 months

Jim Simons Holding value: $49.7 Million Ken Griffin Holding value: $16.2 Million Bill Miller Holding value: $2.77 Million Ray Dalio Holding value: $1.44 Million Chuck Royce Holding value: $558 Thousand Steven Cohen Holding value: $19.7 Thousand Ken Fisher Holding value: $14.5 Thousand Paul Tudor Jones II Holding value: $0 Jefferies Group Holding value: $0 Baillie Gifford Holding value: $0 Polen Capital Holding value: $0 Jeremy Grantham Holding value: $0 Joel Greenblatt Holding value: $0 George Soros Holding value: $0

Market Cap

$724 Million

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$61.94 - $124.20

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

6.04x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$6.40 (9.63%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $724 Million
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $567 Million
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $6.40 (9.63%)
1 Year Return Profit or loss of share price change plus dividend yield. -31.0%
52-Week High Highest share price in the last 52 weeks. $124.20
52-Week Low Lowest share price in the last 52 weeks. $61.94
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.0
Outstanding Shares The number of shares the company has issued and are held by stockholders. 10.9 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 197 Thousand

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 6.04
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. -16.77
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $10.97
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 0.59
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.88
Enterprise Value to Revenue Enterprise value divided by revenue 0.47
Enterprise Value to EBIT Enterprise Value divided by EBIT 3.77
Total Debt to Enterprise Value Total debt divided by enterprise value 0.0
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.0

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $1.22 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $868 Million
EBIT Earnings before tax and interest payments. $150 Million
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $120 Million
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 9.84%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -36.0%
Return on Equity Equity divided by market cap. 62.11%
Return on Assets Indicates a company's profitability in relation to its total assets. 37.47%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 71.62%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q1 2023 Q2 2023 Q3 2023 Q4 2023

About Medifast Inc

CEO: Daniel Chard

Employees: 550

Industry: Pharmaceutical Preparation Manufacturing

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. William Vitale, a medical doctor, founded Medifast in 1980. He sold his products directly to other doctors, who in turn prescribed them to their patients.

Similar stocks

Opko Health Inc
Opko Health Inc
Bellerophon Therapeutics Inc
Bellerophon Therapeutics Inc
Abeona Therapeutics Inc
Abeona Therapeutics Inc

News

Medifast: Good On Paper, But A Slowdown In Sales Is Very Worrisome

Medifast: Good On Paper, But A Slowdown In Sales Is Very Worrisome

Medifast''s efficiency and profitability metrics are impressive, but its high-priced products may deter customers. Find out why MED stock is a Hold.

Seeking Alpha Seeking Alpha, 7 days ago
5 Best High-Dividend Stocks to Buy Now

5 Best High-Dividend Stocks to Buy Now

In this article, we discuss 5 best high-dividend stocks to buy now. If you want to read our detailed analysis of dividend stocks and their performance in the...

Insider Monkey Insider Monkey, 15 days ago
Medifast: Unveiling A Challenge Beyond Weight Loss Drugs

Medifast: Unveiling A Challenge Beyond Weight Loss Drugs

Medifast stock is down 80% from its mid-2021 peak. Check out my views on MED''s business, profitability, balance sheet and the recently reported Q3 earnings.

Seeking Alpha Seeking Alpha, 22 days ago
Medifast, Inc. (MED) Q3 2023 Earnings Call Transcript

Medifast, Inc. (MED) Q3 2023 Earnings Call Transcript

Medifast, Inc. (NYSE:NYSE:MED) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ETCompany ParticipantsSteven Zenker - Vice President of Investor…

Seeking Alpha Seeking Alpha, 24 days ago
Never miss a trade
To improve your user experience we use cookies.